期刊: CLINICAL LUNG CANCER, 2021; 22 (4)
Real-world surgical prognoses of synchronous multiple primary lung cancer (SMPLC) are still uncertain. This study systematically assessed the long-ter......
期刊: CLINICAL LUNG CANCER, 2021; 22 (4)
This study aimed to validate the prognostic value of the presence of solid components in the mediastinal window in clinical stage I pulmonary subsolid......
期刊: CLINICAL LUNG CANCER, 2021; 22 (4)
We aimed to identify the optimal number of examined lymph nodes (ELNs) in sublobar resection (SLR) and assess the survival differences between SLR wit......
期刊: CLINICAL LUNG CANCER, 2021; 22 (4)
The survival benefit of extended sleeve lobectomy (ESL) is unclear, and preoperative selection remains controversial. Twenty-three patients underwent ......
期刊: CLINICAL LUNG CANCER, 2021; 22 (2)
We studied the effect of any steroid use in patients with advanced non-small-cell lung cancer receiving immunotherapy with first-line pembrolizumab, a......
期刊: CLINICAL LUNG CANCER, 2021; 22 (2)
Brain radiotherapy (BR) is a well-recognized approach for multiple brain metastases (BMs) from non small-cell lung cancer (NSCLC). However, the progno......
期刊: CLINICAL LUNG CANCER, 2021; 22 (2)
We investigated the potential use of mutant TP53 in prediction and prognosis of patients with non-small cell lung cancer. We analyzed data obtained fr......
期刊: CLINICAL LUNG CANCER, 2021; 22 (3)
Recurrence of lung cancer in the carina region-induced severe right main bronchial stenosis after pneumonectomy is a challenging clinical problem. Des......
期刊: CLINICAL LUNG CANCER, 2021; 22 (2)
The optimal resection for patients with clinical stage I ground-glass opacity (GGO) lung adenocarcinomas with maximum diameters ? 2 cm remains controv......
期刊: CLINICAL LUNG CANCER, 2021; 22 (2)
Background: Osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, is now a standard treatment of previous......
期刊: CLINICAL LUNG CANCER, 2021; 22 (3)
This study aimed to compare the efficacy and safety of simultaneous EGFR tyrosine kinase inhibitor (TKI) and chemotherapy with that of sequential trea......